Literature DB >> 20049847

Cell-fusion-mediated somatic-cell reprogramming: a mechanism for tissue regeneration.

Frederic Lluis1, Maria Pia Cosma.   

Abstract

Spontaneous cell fusion between two cells of different lineages will originate new hybrid cells that have different features from the original parent cells. It has been shown that injury to a tissue can enhance spontaneous cell-cell fusion events. If one of the parent cells of a cell-cell fusion is highly plastic, such as a stem cell, and the other is a somatic cell, their fusion can be followed by reprogramming events that can generate new hybrid pluripotent cells. These, in turn, have the potential to differentiate and regenerate the damaged tissue. However, if this process is deregulated, this would provide a mechanism for cancer development. J. Cell. Physiol. 223: 6-13, 2010. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20049847     DOI: 10.1002/jcp.22003

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  27 in total

1.  Characterization of Pax3-expressing cells from adult blood vessels.

Authors:  Olivier Goupille; Giorgia Pallafacchina; Frédéric Relaix; Simon J Conway; Ana Cumano; Benoit Robert; Didier Montarras; Margaret Buckingham
Journal:  J Cell Sci       Date:  2011-12-08       Impact factor: 5.285

2.  Bone marrow expression of poly(ADP-ribose) polymerase underlies diabetic neuropathy via hematopoietic-neuronal cell fusion.

Authors:  Tomoya Terashima; Hideto Kojima; Lawrence Chan
Journal:  FASEB J       Date:  2011-10-06       Impact factor: 5.191

3.  CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.

Authors:  Changjun Zeng; Yanling Zhang; Su Cheol Park; Jong Ryeol Eun; Ngoc Tue Nguyen; Benjamin Tschudy-Seney; Yong Jin Jung; Neil D Theise; Mark A Zern; Yuyou Duan
Journal:  Stem Cells Dev       Date:  2015-08-19       Impact factor: 3.272

Review 4.  Pathogenesis of diabetic neuropathy: bad to the bone.

Authors:  Lawrence Chan; Tomoya Terashima; Hiroshi Urabe; Fan Lin; Hideto Kojima
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 5.  Polyploidy in liver development, homeostasis and disease.

Authors:  Romain Donne; Maëva Saroul-Aïnama; Pierre Cordier; Séverine Celton-Morizur; Chantal Desdouets
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-02       Impact factor: 46.802

Review 6.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

7.  Development of Donor Recipient Chimeric Cells of bone marrow origin as a novel approach for tolerance induction in transplantation.

Authors:  Joanna Cwykiel; Maria Madajka-Niemeyer; Maria Siemionow
Journal:  Stem Cell Investig       Date:  2021-04-19

8.  Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts.

Authors:  Joanna Cwykiel; Arkadiusz Jundzill; Aleksandra Klimczak; Maria Madajka-Niemeyer; Maria Siemionow
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-05-10       Impact factor: 4.291

9.  The Wnt/β-catenin signaling pathway tips the balance between apoptosis and reprograming of cell fusion hybrids.

Authors:  Frederic Lluis; Elisa Pedone; Stefano Pepe; Maria Pia Cosma
Journal:  Stem Cells       Date:  2010-11       Impact factor: 6.277

10.  A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer.

Authors:  Rossitza Lazova; Greggory S Laberge; Eric Duvall; Nicole Spoelstra; Vincent Klump; Mario Sznol; Dennis Cooper; Richard A Spritz; Joseph T Chang; John M Pawelek
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.